These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9266991)

  • 1. Immunization with a mouse mammary tumour virus envelope protein epitope protects against tumour formation without inhibition of the virus infection.
    Astori M; Karapetian O
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1935-9. PubMed ID: 9266991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to the C-terminal dipeptide of mouse mammary tumor virus [MMTV(SW)] superantigen effectively inhibit T-cell activation in vivo.
    Astori M; Karapetian O
    J Gen Virol; 1998 Jan; 79 ( Pt 1)():57-60. PubMed ID: 9460923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV; Dudley JP; Ross SR
    J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
    Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
    Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increases in IgA(+) B cells in Peyer's patches during milk-borne mouse mammary tumor virus infection are influenced by Toll-like receptor 4 and are completely dependent on the superantigen response.
    Cabrera G; Vercelli C; Burzyn D; Badano N; Maglioco A; Costa H; Mundiñano J; Camicia G; Nepomnaschy I; Piazzon I
    J Gen Virol; 2010 Nov; 91(Pt 11):2814-20. PubMed ID: 20685932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive immunization with neutralizing antibodies interrupts the mouse mammary tumor virus life cycle.
    Mpandi M; Otten LA; Lavanchy C; Acha-Orbea H; Finke D
    J Virol; 2003 Sep; 77(17):9369-77. PubMed ID: 12915552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BALB/Mtv-null mice responding to strong mouse mammary tumor virus superantigens restrict mammary tumorigenesis.
    Bhadra S; Lozano MM; Dudley JP
    J Virol; 2009 Jan; 83(1):484-8. PubMed ID: 18922863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
    Champagne E; Scarpellino L; Lane P; Acha-Orbea H
    Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early increases in superantigen-specific Foxp3+ regulatory T cells during mouse mammary tumor virus infection.
    Cabrera G; Burzyn D; Mundiñano J; Courreges MC; Camicia G; Lorenzo D; Costa H; Ross SR; Nepomnaschy I; Piazzon I
    J Virol; 2008 Aug; 82(15):7422-31. PubMed ID: 18495774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ; Novick MB; Palmer LD; Knepper JE
    J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD; Saha B; Hodes RJ; Abe R
    J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
    Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H
    J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of two infectious mouse mammary tumour viruses: superantigenicity and tumorigenicity.
    Buggiano V; Goldman A; Nepomnaschy I; Bekinschtein P; Berguer P; Lombardi G; Deroche A; Francisco MV; Piazzon I
    Scand J Immunol; 1999 Mar; 49(3):269-77. PubMed ID: 10102644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
    J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
    Wrona TJ; Lozano M; Binhazim AA; Dudley JP
    J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulatory T cell depletion increases the number of CD8 cells during mouse mammary tumor virus infection].
    Cabrera G; Mundiñano J; Camicia G; Costa H; Nepomnaschy I; Piazzon I
    Medicina (B Aires); 2011; 71(3):243-6. PubMed ID: 21745773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Virology; 1996 Sep; 223(2):387-91. PubMed ID: 8806576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal infection with a milk-borne virus is independent of beta7 integrin- and L-selectin-expressing lymphocytes.
    Czarneski J; Berguer P; Bekinschtein P; Kim DC; Hakimpour P; Wagner N; Nepomnaschy I; Piazzon I; Ross SR
    Eur J Immunol; 2002 Apr; 32(4):945-56. PubMed ID: 11920560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrovirus-host interactions. The mouse mammary tumor virus model.
    Acha-Orbea H
    Medicina (B Aires); 1997; 57 Suppl 2():43-52. PubMed ID: 9567343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
    J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.